Skip to main content
. 2024 Jan 29;32(1):84–92. doi: 10.5606/tgkdc.dergisi.2024.25394

Figure 1. Survival analyses according to cut-off value of 50% in cases with PD-L1 expression on cancer cells and PD-L1 expression on lymphocytes in adenocarcinoma. PD-L1: Programmed death-ligand 1.

Figure 1